- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05811780
The University of Freiburg Medical Center Extracorporeal Organ Support Device Registry
March 31, 2023 updated by: PD Dr. Alexander Supady, University Hospital Freiburg
A prospective registry collecting pseudonymized clinical and treatment data from all patients treated with extracorporeal organ support (i.e., VV ECMO, VA ECMO, ECPR, Impella, IABP, and others) on the wards of the Department of Interdisciplinary Medical Intensive Care at the Freiburg University Medical Center.
Study Overview
Status
Recruiting
Study Type
Observational
Enrollment (Anticipated)
1500
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Tobias Wengenmayer, Prof. Dr.
- Phone Number: 35910 +49761270
- Email: tobias.wengenmayer@uniklinik-freiburg.de
Study Contact Backup
- Name: Alexander Supady, PD Dr.
- Phone Number: 73790 +49761270
- Email: alexander.supady@uniklinik-freiburg.de
Study Locations
-
-
-
Freiburg, Germany, 79106
- Recruiting
- University of Freiburg Medical Center
-
Contact:
- Tobias Wengenmayer, Prof. Dr.
- Phone Number: 35910 +49761270
- Email: tobias.wengenmayer@uniklinik-freiburg.de
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
All patients receiving extracorporeal organ support and being treated in the Department of Interdisciplinary Medical Intensive Care of the Freiburg University Medical Center
Description
Inclusion Criteria:
- Treatment with any kind of extracorporeal organ support
Exclusion Criteria:
- none
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hospital survival
Time Frame: 30 days
|
Survival of index hospitalization (yes/no)
|
30 days
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mesenteric ischemia
Time Frame: 30 days
|
Occurrence of mesenteric ischemia
|
30 days
|
|
Fluid balance
Time Frame: 7 days
|
Patient fluid balance (difference between fluid input and output)
|
7 days
|
|
ECMO run-time
Time Frame: 60 days
|
Duration of ECMO support
|
60 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Tobias Wengenmayer, Prof. Dr., University of Freiburg
- Principal Investigator: Dawid L Staudacher, PD Dr., University of Freiburg
- Principal Investigator: Paul M Biever, Dr., University of Freiburg
- Principal Investigator: Jonathan Rilinger, PD Dr., University of Freiburg
- Principal Investigator: Alexander Supady, PD Dr., University of Freiburg
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 29, 2014
Primary Completion (Anticipated)
December 31, 2030
Study Completion (Anticipated)
December 31, 2035
Study Registration Dates
First Submitted
March 20, 2023
First Submitted That Met QC Criteria
March 31, 2023
First Posted (Actual)
April 13, 2023
Study Record Updates
Last Update Posted (Actual)
April 13, 2023
Last Update Submitted That Met QC Criteria
March 31, 2023
Last Verified
March 1, 2023
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 151/14
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Medical Condition Requiring Extracorporeal Organ Support
-
Juan Blanco MorilloInstituto Murciano de Investigación Biosanitaria Virgen de la ArrixacaCompletedEmbolism, Air | Anemia | Cardiac Disease | Valve Anomalies | Extracorporeal Circulation; Complications | Transfusion | Cognitive; Disorder, Due to General Medical ConditionSpain